Pathophysiology Quiz
20 questions · no time limit
0:00
GI AND HEPATOBILIARY PATHOPHYSIOLOGY
Question 1 of 20
No time limit
Current
Answered
Flagged
Not seen
A physician considers prescribing celecoxib, a selective COX-2 inhibitor, over naproxen, a non-selective COX inhibitor, for a patient with a history of PUD. The theoretical basis for celecoxib's improved gastric safety profile is its relative sparing of which enzyme's activity?
YOUR PROGRESS
20
QUESTIONS
Ready when you are
Answer in any order. Your progress shows here as you go.
QUESTIONS
KEYBOARD
Pick an answer ABCD
Next question ↵→
Previous ←
Flag for review F
Answers save as you go · flagged questions come back at the end